Interstitial MR lymphography in Mice: Comparative study with gadofluorine 8, gadofluorine M, and gadofluorine P

Magnetic Resonance in Medical Sciences

Volumn 11, Issue 2, 2012, Pages 99-107

  Kiryu, Shigeru ^a   Inoue, Yusuke ^b   Sheng, Fugeng ^c   Watanabe, Makoto ^a   Yoshikawa, Kohki ^d   Shimada, Morio ^d   Ohtomo, Kuni ^e  

^a UNIVERSITY OF TOKYO   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^d KOMAZAWA UNIVERSITY   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

Interstitial MR lymphography; Lymph nodes; Magnetic resonance imaging; Mouse

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOFLUORINE 8; GADOFLUORINE M; ORGANOMETALLIC COMPOUND;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; COMPARATIVE STUDY; DIFFUSION WEIGHTED IMAGING; EVALUATION; FEMALE; HISTOLOGY; HUMAN; IMAGE ENHANCEMENT; LYMPHATIC SYSTEM; LYMPHOGRAPHY; METHODOLOGY; MOUSE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ANIMALS; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE ENHANCEMENT; LYMPHATIC SYSTEM; LYMPHOGRAPHY; MICE; MICE, INBRED BALB C; ORGANOMETALLIC COMPOUNDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84863830198     PISSN: 13473182     EISSN: 18802206     Source Type: Journal    
DOI: 10.2463/mrms.11.99     Document Type: Article

References (27)

1. Hayashi H, Tangoku A, Suga K, et al. CT lym-phography-navigated sentinel lymph node biopsy in patients with superficial esophageal cancer. Surgery 2006; 139:224-235.
2. Suga K, Yuan Y, Okada M, et al. Breast sentinel lymph node mapping at CT lymphography with iopamidol:preliminaryexperience. Radiology 2004; 230:543-552.
3. Chung YE, Hyung WJ, Kweon S, et al. Feasibility of interstitial CT lymphography using optimized iodized oil emulsion in rats. Invest Radiol 2010; 45:142-148.
4. Choi SH, Kono Y, Corbeil J, Lucidarme O, Mattrey RF. Model to quantify lymph node enhancement on indirect sonographic lymphography. AJR Am J Roentgenol 2004; 183:513-517.
5. Mattrey RF, Kono Y, Baker K, Peterson T. Sentinel lymph node imaging with microbubble ultra-sound contrast material. Acad Radiol 2002; 9 (Suppl 1):S231-S235.
6. Kobayashi H, Kawamoto S, Sakai Y, et al. Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent. J Natl Cancer Inst 2004; 96:703-708.
7. Mounzer R, Shkarin P, Papademetris X, Constable T, Ruddle NH, Fahmy TM. Dynamic imaging of lymphatic vessels and lymph nodes using a bimodal nanoparticulate contrast agent. Lym-phat Res Biol 2007; 5:151-158.
8. Kiryu S, Inoue Y, Yoshikawa K, Shimada M, Watanabe M, Ohtomo K. Diet and gastrointestinal signal on T1-weighted magnetic resonance imaging of mice. Magn Reson Imaging 2010; 28:273-280.
9. Kobayashi H, Kawamoto S, Choyke PL, et al. Comparison of dendrimer-based macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiography. Magn Reson Med 2003; 50:758-766.
10. Sheng F, Inoue Y, Kiryu S, Watanabe M, Ohtomo K. Interstitial MR lymphography in mice with gad-opentetate dimeglumine and gadoxetate disodium. J Magn Reson Imaging 2011; 33:490-497.
11. Misselwitz B. MR contrast agents in lymph node imaging. Eur J Radiol 2006; 58:375-382.
12. Misselwitz B, Platzek J, Raduächel B, Oellinger JJ, Weinmann HJ. Gadofluorine 8: initial experience with a new contrast medium for interstitial MR lymphography. MAGMA 1999; 8:190-195.
13. Staatz G, Nolte-Ernsting CC, Adam GB, et al. Interstitial T1-weighted MR lymphography: lipophil-ic perfluorinated gadolinium chelates in pigs. Radiology 2001; 220:129-134.
14. Shimada M, Yoshikawa K, Suganuma T, et al. Interstitial magnetic resonance lymphography: comparative animal study of gadofluorine 8 and gadolinium diethylenetriamine-pentaacetic acid. J Comput Assist Tomogr 2003; 27:641-646.
15. Inoue Y, Masutani Y, Kiryu S, et al. Integrated lymphography using fluorescence imaging and magnetic resonance imaging in intact mice. Mol Imaging 2011; 10:317-326.
16. Bendszus M, Ladewig G, Jestaedt L, et al. Gadofluorine M enhancement allows more sensitive detection of inflammatory CNS lesions than T2-w imaging: a quantitative MRI study. Brain 2008; 131(Pt 9):2341-2352.
17. Ladewig G, Jestaedt L, Misselwitz B, et al. Spatial diversity of blood-brain barrier alteration and mac-rophage invasion in experimental autoimmune en-cephalomyelitis: a comparative MRI study. Exp Neurol 2009; 220:207-211.
18. Bendszus M, Stoll G. Technology insight: visualizing peripheral nerve injury using MRI. Nat Clin Pract Neurol 2005; 1:45-53.
19. Sirol M, Itskovich VV, Mani V, et al. Lipid-rich atherosclerotic plaques detected by gadofluorine-enhanced in vivo magnetic resonance imaging. Circulation 2004; 109:2890-2896.
20. Henning TD, Saborowski O, Golovko D, et al. Cell labeling with the positive MR contrast agent Gadofluorine M. Eur Radiol 2007; 17:1226-1234.
21. Misselwitz B, Platzek J, Weinmann HJ. Early MR lymphography with gadofluorine M in rabbits. Radiology 2004; 231:682-688.
22. Choi SH, Han MH, Moon WK, et al. Cervical lymph node metastases: MR imaging of gadofluorine M and monocrystalline iron oxide nanoparticle-47 in a rabbit model of head and neck cancer. Radiology 2006; 241:753-762.
23. Misselwitz B, Meding J, Reinhardt M, Weinmann H. Gadofluorine P: Initial experiences with a new MR contrast medium: MR imaging of atherosclerotic plaques. In: Book of abstracts: 93rd Scientific Assembly and Annual Meeting of the Radiological Society of North America, Chicago, IL; RSNA, 2007; 238-239.
24. Inoue Y, Nomura Y, Haishi T, et al. Imaging living mice using a 1-T compact MRI system. J Magn Reson Imaging 2006; 24:901-907.
25. Haishi T, Uematsu T, Matsuda Y, Kose K. Development of a 1.0 T MR microscope using a Nd-Fe-B permanent magnet. Magn Reson Imaging 2001; 19:875-880.
26. Braeutigam M, invivoContrast GmbH, Berlin, Germany. Personal communication.
27. Harrell MI, Iritani BM, Ruddell A. Lymph node mapping in the mouse. J Immunol Methods 2008; 332:170-174.